Christine Kapaun

Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials

M. Stauch, V. Heinemann, T. Decker, 2020, Clinical Cancer Research.

Cetuximab-related skin toxicity in metastatic colorectal cancer (mCRC) patients and its correlation with molecular markers: Results from the German AIO CRC 0104 trial.

V. Heinemann, A. Wollenberg, J. Neumann, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ligand expression of the EGFR ligands amphiregulin, epiregulin, and amplification of the EGFR gene to predict for treatment efficacy in KRAS wild-type mCRC patients treated with cetuximab plus CAPIRI and CAPOX: Analysis of the randomized AIO CRC-0104 trial.

M. Stauch, V. Heinemann, H. Hass, 2012 .

Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group

V. Heinemann, A. Wollenberg, J. Neumann, 2013, International journal of cancer.